1. de Wet, Larischa, Williams, Anthony, Gillard, Marc, Szmulewitz, Russell Z, Vander Griend, Donald J. 2022. SOX2 mediates metabolic reprogramming of prostate cancer cells. In Oncogene, 41, 1190-1202. doi:10.1038/s41388-021-02157-x. https://pubmed.ncbi.nlm.nih.gov/35067686/
2. Bhadwal, Priyanka, Randhawa, Vinay, Vaiphei, Kim, Dahiya, Divya, Agnihotri, Navneet. 2022. Clinical relevance of CERK and SPHK1 in breast cancer and their association with metastasis and drug resistance. In Scientific reports, 12, 18239. doi:10.1038/s41598-022-20976-0. https://pubmed.ncbi.nlm.nih.gov/36309544/
3. Ordoñez, Marta, Presa, Natalia, Trueba, Miguel, Gomez-Muñoz, Antonio. 2017. Implication of Ceramide Kinase in Adipogenesis. In Mediators of inflammation, 2017, 9374563. doi:10.1155/2017/9374563. https://pubmed.ncbi.nlm.nih.gov/28951635/
4. Dong, Wei, Li, Qing, Lu, Xing, Zhang, Chong, Jin, Junfei. 2024. Ceramide kinase-mediated C1P metabolism attenuates acute liver injury by inhibiting the interaction between KEAP1 and NRF2. In Experimental & molecular medicine, 56, 946-958. doi:10.1038/s12276-024-01203-4. https://pubmed.ncbi.nlm.nih.gov/38556546/
5. Bornancin, Frédéric. 2010. Ceramide kinase: the first decade. In Cellular signalling, 23, 999-1008. doi:10.1016/j.cellsig.2010.11.012. https://pubmed.ncbi.nlm.nih.gov/21111813/